Mural Oncology plc
MURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $42,662 | $21,633 | $54,963 |
| - Cash | $58,871 | $77,094 | $106,682 | $115,462 |
| + Debt | $0 | $5,173 | $6,784 | $8,022 |
| Enterprise Value | – | -$29,259 | -$78,265 | -$52,477 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$1,100 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,909 | -$46,882 | -$33,533 | -$34,986 |
| % Margin | – | – | – | – |
| Net Income | -$3,706 | -$47,982 | -$33,137 | -$34,274 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.21 | -2.78 | -1.93 | -2.01 |
| % Growth | 92.4% | -44% | 4% | – |
| Operating Cash Flow | -$18,481 | -$31,363 | -$36,798 | -$31,770 |
| Capital Expenditures | $0 | -$5 | -$10 | -$23 |
| Free Cash Flow | -$18,481 | -$31,368 | -$36,808 | -$31,793 |